Cold allodynia, pain in response to cooling, occurs during or within hours of oxaliplatin infusion and is thought to arise from a direct effect of oxaliplatin on peripheral sensory neurons. To characterize the pathophysiological mechanisms underlying acute oxaliplatin-induced cold allodynia, we established a new intraplantar oxaliplatin mouse model that rapidly developed long-lasting cold allodynia mediated entirely through tetrodotoxin-sensitive Na v pathways. Using selective inhibitors and knockout animals, we found that Na v 1.6 was the key isoform involved, while thermosensitive transient receptor potential channels were not involved. Consistent with a crucial role for delayed-rectifier potassium channels in excitability in response to cold, intraplantar administration of the K + -channel blocker 4-aminopyridine mimicked oxaliplatin-induced cold allodynia and was also inhibited by Na v 1.6 blockers. Intraplantar injection of the Na v 1.6 activator Cn2 elicited spontaneous pain, mechanical allodynia, and enhanced 4-aminopyridine-induced cold allodynia. These findings provide behavioural evidence for a crucial role of Na v 1.6 in multiple peripheral pain pathways including cold allodynia. Ó
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Introduction
Oxaliplatin, a third-generation platinum chemotherapeutic agent, is associated with acute dose-limiting neurotoxicity, which manifests as cooling-induced peripheral dysaesthesias and paraesthesias including cold allodynia [6, 12] . Acute oxaliplatin-induced cold allodynia is characterized by a rapid onset, with symptoms occurring during or shortly after infusion, and typically resolves within several days of treatment [5] . Many currently used animal models of oxaliplatin-induced neuropathy poorly reflect these characteristics, and often require multiple injections of oxaliplatin to elicit pain behaviours which develop slowly and are of prolonged duration [29, 39, 54] . Mechanistic studies in these animal models have attributed expressional changes and altered function of ion channels expressed on unmyelinated C-fibre nociceptors to the development of cold allodynia, such as the transient receptor potential (TRP) channels TRPM8, TRPA1, and the two-pore domain potassium (K + ) channels TREK1 and TRAAK [16, 21, 34, 58] . However, these findings are inconsistent with the clinical time course of acute oxaliplatin-induced cold allodynia and the predominant effects of oxaliplatin on myelinated A-fibres [2,6,26,45,46]. Thus, the pathophysiological mechanisms underlying acute oxaliplatin-induced cold allodynia remain unclear. While oxaliplatin-induced allodynia has been described as an axonal channelopathy resulting from modulation of neuronal Na v channels [35] , the contributions of the nine described isoforms (Na v 1.1-Na v 1.9) have not been systematically assessed.
Dorsal root ganglion (DRG) neurons express several Na v isoforms, including the tetrodotoxin (TTX)-resistant isoforms Na v 1.8 and Na v 1.9, as well as the TTX-sensitive isoforms Na v 1.1, Na v 1.2, Na v 1.3, Na v 1.6, and Na v 1.7 [40] . The TTX-resistant Na v isoform Na v 1.8 in particular has been found to be crucial for pain evoked by noxious cold [59], while Na v 1.9 has been suggested to contribute to the pathogenesis of neuropathic pain [28] . In addition, Na v 1.7 is known to be crucial in pain pathways, as loss-of-function mutations in humans cause congenital insensitivity to pain [14] , while gain-of-function mutations are associated with painful conditions such as erythromelalgia and paroxysmal extreme pain disorder
